Zimmer Biomet stock slips as guidance and jobs cuts weigh

Published on 09/10/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zimmer Biomet stock traded at USD 94.22 on September 8, 2026, after a 3.9 percent drop. Q2 2026 EPS was USD 2.07 on revenue of USD 2.18 billion.

Titan-Knieimplantat auf Edelstahltisch in steriler Medizintechnik-Fertigung — Zimmer Biomet US98956P1021 zeigt Titan-Knieimplantat mit orthopädischen Instrumenten in steriler Fertigungsumgebung nahaufnahme, Illustration mit AI erstellt.

Zimmer Biomet stock (ISIN US98956P1021) traded at USD 94.22 on September 8, 2026, down 3.9 percent from the prior close. The move came as the company kept investors focused on Q2 2026 EPS of USD 2.07 and revenue of USD 2.18 billion, both figures reported for the quarter ended June 30, 2026.

Guidance still drives the story

According to MarketBeat, Zimmer Biomet's Q2 2026 earnings of USD 2.07 a share beat the consensus estimate of USD 2.01 by USD 0.06 on August 5, 2026. The same report said revenue rose 4.8 percent year over year to USD 2.18 billion and that full-year 2026 adjusted EPS guidance stood at USD 8.47 to USD 8.59.

That guidance matters because the top end of the range now sits USD 0.04 above the prior high end of USD 8.55. MarketBeat also cited a market capitalization of USD 18.08 billion, 1.994 million shares traded and a 52-week range of USD 79.12 to USD 106.88.

Jobs cuts add pressure

As swissinfo reported on September 9, 2026, Zimmer Biomet is planning to cut up to 580 jobs in Winterthur. The report said the site has about 730 positions, so the planned reduction would affect most of the local workforce.

The same day, ad hoc news cited GuruFocus data showing the stock at USD 94.22, about 24.6 percent below a GF Value estimate of USD 124.90. The same article said the shares were trading in the middle of their USD 79.12 to USD 106.88 52-week band.

Stock near mid-range

Zimmer Biomet stock remained at USD 94.22 on the New York Stock Exchange as of September 8, 2026. That left the shares above the 52-week low by USD 15.10 and below the 52-week high by USD 12.66.